Abstract:Aim: To investigate the abundance and potential diagnostic significance of neuroligin-1 and glutamate (Glu) in Hirschsprung's disease (HSCR). Methods: Ninety children with HSCR and 50 children without HSCR matched for similar nutritional status, age and basal metabolic index were studied. The expression and localization of neuroligin-1 and Glu were assessed using double-labeling immunofluorescence staining of longitudinal muscles with adherent myenteric plexus from the surgically excised colon of children with HSCR. Western blot analysis, quantitative real-time PCR (qRT-PCR) and immunohistochemistry were performed to evaluate the abundance of neuroligin-1 and Glu in different HSCR-affected segments (ganglionic, transitional, and aganglionic segments). Enzyme-linked immunosorbent assay (ELISA) was used to detect and compare serum Glu levels in the long-segment HSCR, short-segment HSCR and non-HSCR samples. Results: Neuroligin-1 and Glu were co-expressed highest to lowest in the ganglionic, transitional and aganglionic segments based on Western blot (neuroligin-1: 0.177 ± 0.008 vs 0.101 ± 0.006, 0.177 ± 0.008 vs 0.035 ± 0.005, and 0.101 ± 0.006 vs 0.035 ± 0.005, P < 0.005; Glu: 0.198 ± 0.006 vs 0.115 ± 0.008, 0.198 ± 0.006 vs 0.040 ± 0.003, and 0.115 ± 0.008 vs 0.040 ± 0.003, P < 0.005) and qRT-PCR (neuroligin-1: 9.58 × 10(-5) ± 9.94 × 10(-6) vs 2.49 × 10(-5) ± 1.38 × 10(-6), 9.58 × 10(-5) ± 9.94 × 10(-6) vs 7.17 × 10(-6 ±) 1.12 × 10(-6), and 2.49 × 10(-5) ± 1.38 × 10(-6) vs 7.17 × 10(-6) ± 1.12 × 10(-6), P < 0.005). Serum Glu level was the highest to lowest in the non-HSCR, short-type HSCR and long-type HSCR samples based on ELISA (in nmol/μL, 0.93 ± 0.31 vs 0.57 ± 0.25, 0.93 ± 0.31 vs 0.23 ± 0.16, and 0.57 ± 0.25 vs 0.23 ± 0.16, P < 0.005). Conclusion: Neuroligin-1 and Glu may represent new markers of ganglion cells, whose expression may correlate with the pathogenesis, diagnosis, differential diagnosis or classification of HSCR.

Proteomic Analysis Provides a New Sight Into the CRABP1 Expression in the Pathogenesis of Hirschsprung Disease

Comparative Proteomics of Hirschsprung's Disease

Comparative Study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's Disease

Comparative Proteomic Profiles of the Normal and Aganglionic Hindgut in Human Hirschsprung Disease.

Differential Expressions of BMPR1α, ACTN4α and FABP7 in Hirschsprung Disease.

Downregulation of Notch-1/Jagged-2 in human colon tissues from Hirschsprung disease patients

Expression of Dishevelled Gene in Hirschsprung's Disease.

Polymorphisms and Expression of the Wnt8a Gene in Hirschsprung'S Disease

The Single Nucleotide Polymorphisms in Smad-interacting Protein 1 Gene Contribute to Its Ectopic Expression and Susceptibility in Hirschsprung's Disease.

Expression Analysis of Bmp2, Bmp5, Bmp10 in Human Colon Tissues from Hirschsprung Disease Patients

Expression Patterns of Dishevelled-2 in Different Colon Tissue Segments in Hirschsprung's Disease.

Multiple 'Omics'-Analysis Reveals the Role of Prostaglandin E2 in Hirschsprung's Disease

A Pilot Study: Transcriptional Profiling, Functional Analysis, and Organoid Modeling of Intestinal Mucosa in Hirschsprung Disease

Study of the Effect of Mir-124 and the Sox9 Target Gene in Hirschsprung'S Disease

Aberrant Development of Enteric Glial Cells in the Colon of Hirschsprung's Disease

Expression Patterns of Cxcr4 in Different Colon Tissue Segments of Patients with Hirschsprung'S Disease

Abundance and significance of neuroligin-1 and glutamate in Hirschsprung's disease

mRNA sequencing provides new insights into the pathogenesis of Hirschsprung's disease in mice

Weighted Gene Coexpression Network Analysis Reveals the Critical lncRNAs and mRNAs in Development of Hirschsprung's Disease

Microarray Expression Profiling of Dysregulated Long Non-Coding Rnas in Hirschsprung'S Disease Reveals Their Potential Role in Molecular Diagnosis

Wnt3a Gene Expression is Associated with Isolated Hirschsprung Disease Polymorphism and Disease Status